Cargando…
Heparin-binding protein is important for vascular leak in sepsis
BACKGROUND: Elevated plasma levels of heparin-binding protein (HBP) are associated with risk of organ dysfunction and mortality in sepsis, but little is known about causality and mechanisms of action of HBP. The objective of the present study was to test the hypothesis that HBP is a key mediator of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050173/ https://www.ncbi.nlm.nih.gov/pubmed/27704481 http://dx.doi.org/10.1186/s40635-016-0104-3 |
_version_ | 1782457829812076544 |
---|---|
author | Bentzer, Peter Fisher, Jane Kong, HyeJin Julia Mörgelin, Mattias Boyd, John H. Walley, Keith R. Russell, James A. Linder, Adam |
author_facet | Bentzer, Peter Fisher, Jane Kong, HyeJin Julia Mörgelin, Mattias Boyd, John H. Walley, Keith R. Russell, James A. Linder, Adam |
author_sort | Bentzer, Peter |
collection | PubMed |
description | BACKGROUND: Elevated plasma levels of heparin-binding protein (HBP) are associated with risk of organ dysfunction and mortality in sepsis, but little is known about causality and mechanisms of action of HBP. The objective of the present study was to test the hypothesis that HBP is a key mediator of the increased endothelial permeability observed in sepsis and to test potential treatments that inhibit HBP-induced increases in permeability. METHODS: Association between HBP at admission with clinical signs of increased permeability was investigated in 341 patients with septic shock. Mechanisms of action and potential treatment strategies were investigated in cultured human endothelial cells and in mice. RESULTS: Following adjustment for comorbidities and Acute Physiology and Chronic Health Evaluation (APACHE) II, plasma HBP concentrations were weakly associated with fluid overload during the first 4 days of septic shock and the degree of hypoxemia (PaO(2)/FiO(2)) as measures of increased systemic and lung permeability, respectively. In mice, intravenous injection of recombinant human HBP induced a lung injury similar to that observed after lipopolysaccharide injection. HBP increased permeability of vascular endothelial cell monolayers in vitro, and enzymatic removal of luminal cell surface glycosaminoglycans (GAGs) using heparinase III and chondroitinase ABC abolished this effect. Similarly, unfractionated heparins and low molecular weight heparins counteracted permeability increased by HBP in vitro. Intracellular, selective inhibition of protein kinase C (PKC) and Rho-kinase pathways reversed HBP-mediated permeability effects. CONCLUSIONS: HBP is a potential mediator of sepsis-induced acute lung injury through enhanced endothelial permeability. HBP increases permeability through an interaction with luminal GAGs and activation of the PKC and Rho-kinase pathways. Heparins are potential inhibitors of HBP-induced increases in permeability. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40635-016-0104-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5050173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-50501732016-10-18 Heparin-binding protein is important for vascular leak in sepsis Bentzer, Peter Fisher, Jane Kong, HyeJin Julia Mörgelin, Mattias Boyd, John H. Walley, Keith R. Russell, James A. Linder, Adam Intensive Care Med Exp Research BACKGROUND: Elevated plasma levels of heparin-binding protein (HBP) are associated with risk of organ dysfunction and mortality in sepsis, but little is known about causality and mechanisms of action of HBP. The objective of the present study was to test the hypothesis that HBP is a key mediator of the increased endothelial permeability observed in sepsis and to test potential treatments that inhibit HBP-induced increases in permeability. METHODS: Association between HBP at admission with clinical signs of increased permeability was investigated in 341 patients with septic shock. Mechanisms of action and potential treatment strategies were investigated in cultured human endothelial cells and in mice. RESULTS: Following adjustment for comorbidities and Acute Physiology and Chronic Health Evaluation (APACHE) II, plasma HBP concentrations were weakly associated with fluid overload during the first 4 days of septic shock and the degree of hypoxemia (PaO(2)/FiO(2)) as measures of increased systemic and lung permeability, respectively. In mice, intravenous injection of recombinant human HBP induced a lung injury similar to that observed after lipopolysaccharide injection. HBP increased permeability of vascular endothelial cell monolayers in vitro, and enzymatic removal of luminal cell surface glycosaminoglycans (GAGs) using heparinase III and chondroitinase ABC abolished this effect. Similarly, unfractionated heparins and low molecular weight heparins counteracted permeability increased by HBP in vitro. Intracellular, selective inhibition of protein kinase C (PKC) and Rho-kinase pathways reversed HBP-mediated permeability effects. CONCLUSIONS: HBP is a potential mediator of sepsis-induced acute lung injury through enhanced endothelial permeability. HBP increases permeability through an interaction with luminal GAGs and activation of the PKC and Rho-kinase pathways. Heparins are potential inhibitors of HBP-induced increases in permeability. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40635-016-0104-3) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-10-04 /pmc/articles/PMC5050173/ /pubmed/27704481 http://dx.doi.org/10.1186/s40635-016-0104-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Bentzer, Peter Fisher, Jane Kong, HyeJin Julia Mörgelin, Mattias Boyd, John H. Walley, Keith R. Russell, James A. Linder, Adam Heparin-binding protein is important for vascular leak in sepsis |
title | Heparin-binding protein is important for vascular leak in sepsis |
title_full | Heparin-binding protein is important for vascular leak in sepsis |
title_fullStr | Heparin-binding protein is important for vascular leak in sepsis |
title_full_unstemmed | Heparin-binding protein is important for vascular leak in sepsis |
title_short | Heparin-binding protein is important for vascular leak in sepsis |
title_sort | heparin-binding protein is important for vascular leak in sepsis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050173/ https://www.ncbi.nlm.nih.gov/pubmed/27704481 http://dx.doi.org/10.1186/s40635-016-0104-3 |
work_keys_str_mv | AT bentzerpeter heparinbindingproteinisimportantforvascularleakinsepsis AT fisherjane heparinbindingproteinisimportantforvascularleakinsepsis AT konghyejinjulia heparinbindingproteinisimportantforvascularleakinsepsis AT morgelinmattias heparinbindingproteinisimportantforvascularleakinsepsis AT boydjohnh heparinbindingproteinisimportantforvascularleakinsepsis AT walleykeithr heparinbindingproteinisimportantforvascularleakinsepsis AT russelljamesa heparinbindingproteinisimportantforvascularleakinsepsis AT linderadam heparinbindingproteinisimportantforvascularleakinsepsis |